site stats

Syrs news

WebSYRS : 1.0200 (-5.56%) Syros to Report First Quarter 2024 Financial Results on Monday, May 16, 2024 Business Wire - Mon May 9, 6:30AM CDT. Syros Pharmaceuticals (NASDAQ:SYRS), a leader in the development of medicines that control the expression of genes, today announced that it will host a live conference call and webcast at 8:30 a.m. ET... WebSyros Pharmaceuticals…. Syros Pharmaceuticals presents safety lead-in data from SELECT-AML-1 trial » 12/11/22. SYRS. Syros Pharmaceuticals…. Syros Pharmaceuticals price target lowered to $16 from $40 at JMP Securities » 11/15/22. SYRS. JMP Securities analyst…. Syros Pharmaceuticals price target lowered to $15 from $30 at Oppenheimer ...

Syros Pharmaceuticals, Inc. (NASDAQ:SYRS) Given Average …

WebMar 31, 2024 · Current Quarter Estimates for SYRS. In the past 30 days, one estimate has gone higher for Syros Pharmaceuticals while no estimates have gone lower in the same time period. The trend has been pretty favorable too, with estimates increasing from a loss of 70 cents a share 30 days ago, to a loss of 61 cents today, a move of 13%. WebSyros Reports Fourth Quarter and Full Year 2024 Financial Results and Provides a Corporate Update. CAMBRIDGE, Mass., March 02, 2024--Syros Pharmaceuticals (NASDAQ:SYRS), a … trigent software gd topics https://slk-tour.com

SYRS - Syros Pharmaceuticals Stock Price - Barchart.com

WebMar 29, 2024 · Get Syros Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for SYRS and its competitors with MarketBeat's FREE … WebApr 10, 2024 · Syros Pharmaceuticals, Inc. (SYRS) delivered earnings and revenue surprises of 38.36% and 21.65%, respectively, for the quarter ended September 2024. Do the … WebSyros Pharmaceuticals Inc. (SYRS) Stock Price Today, News, Quotes, FAQs and Fundamentals DIA 0.42% SPY 0.17% QQQ 0.55% Trending RIOT 14.56% AUPH 10.18% … trigent software chennai

INVESTIGATION NOTICE: Halper Sadeh LLP Investigates RFP, LJPC, FSI, SYRS

Category:Syros Pharmaceuticals - SYRS - Stock Price Today - Zacks

Tags:Syrs news

Syrs news

Syracuse News & Weather Syracuse, NY 9WSYR

WebApr 15, 2024 · Syros Pharmaceuticals Trading Down 2.5 %. Shares of Syros Pharmaceuticals stock opened at $2.70 on Friday. The firm has a market capitalization of $54.81 million, a price-to-earnings ratio of -0. ...

Syrs news

Did you know?

WebNov 15, 2024 · In a regulatory filing, Syros Pharmaceuticals (SYRS) disclosed that, as of March 10, it has two deposit accounts at Silicon Valley Bank. One of these accounts has a balance of less than $250,000, and the other has a balance of approximately $3.1M pursuant to a letter of credit that the company was required to provide to its landlord in connection … WebApr 10, 2024 · Support: 888-992-3836 Home NewsWire Subscriptions ...

WebSYRS (Syros Pharmaceuticals) Other Long Term Assets as of today (April 14, 2024) is $8.43 Mil. Other Long Term Assets explanation, calculation, historical data WebWe tell local Syracuse news & weather stories, and we do what we do to make Syracuse and the rest of New York a better place to live.

WebCAMBRIDGE, Mass., February 23, 2024--Syros Pharmaceuticals (NASDAQ:SYRS), a biopharmaceutical company committed to advancing new standards of care for the frontline treatment of hematologic malignancies, today announced that it will host a live conference call and webcast at 8:30 a.m. ET on Thursday, March 2, 2024 to report its fourth quarter … WebSep 13, 2024 · Ethereum’s price is currently approaching the resistance level of $2008.0. The Buyers have successfully used the retest of the symmetrical triangle to engineer a bullish displacement. Ethereum experienced double bearish impulsive waves that delivered the price from the high of $3487.0 to the support level of $1009.0.

WebNov 7, 2024 · Syros Pharmaceuticals (NASDAQ: SYRS) is one of those companies that any conscientious individual would root for but shouldn’t necessarily invest their hard-earned capital in. Sure, it would be great to see Syros’s clinical programs succeed, but cautious financial traders must acknowledge the odds and accept that failure is a possibility.So, I …

WebApr 6, 2024 · Get Syros Pharmaceuticals Inc (SYRS:NASDAQ) real-time stock quotes, news, price and financial information from CNBC. terrorist among us roleWebNews Press Releases Research Reports SEC Filings Insider Monkey Simply Wall St. Syros Pharmaceuticals Full Year 2024 Earnings: EPS Beats Expectations, Revenues Lag Syros … terrorist alarm clockWebApr 9, 2024 · Syros Pharmaceuticals, Inc. (NASDAQ:SYRS) posted its quarterly earnings data on Thursday, March, 2nd. The company reported ($1.28) EPS for the quarter, missing the … terrorist among usWebApr 6, 2024 · A high-level overview of Syros Pharmaceuticals, Inc. (SYRS) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment … terrorist arrest ottawaWebApr 9, 2024 · SYRS Stock Overview Syros Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of treatment for hematologic malignancies. About the company Rewards Revenue is forecast to grow 58.79% per year Risk Analysis Shareholders have been substantially diluted in the past year terrorist and dark webWebSep 16, 2024 · CAMBRIDGE, Mass.--(BUSINESS WIRE)--Syros Pharmaceuticals, Inc. (NASDAQ:SYRS), a leader in the development of medicines that control the expression of genes, today announced the closing of its ... terrorist antonymWebApr 6, 2024 · SYRS: Syros Pharmaceuticals Inc - Stock Price, Quote and News - CNBC New 52 Week Low Today Syros Pharmaceuticals Inc SYRS:NASDAQ EXPORT WATCHLIST + … trigent software company